Time to reconsider the role of ribavirin in Lassa fever.

Alex Paddy Salam ORCID logo ; Vincent Cheng ORCID logo ; Tansy Edwards ORCID logo ; Piero Olliaro ORCID logo ; Jonathan Sterne ORCID logo ; Peter Horby ORCID logo ; (2021) Time to reconsider the role of ribavirin in Lassa fever. PLoS neglected tropical diseases, 15 (7). e0009522-. ISSN 1935-2727 DOI: 10.1371/journal.pntd.0009522
Copy

Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.
Item Type Article
Elements ID 164354
Date Deposited 27 Aug 2021 18:41

Explore Further

picture_as_pdf
Time to reconsider the role of ribavirin in Lassa fever.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads